Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion type Assertion NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_head.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion description "[Recently, differentiation therapy of acute promyelocytic leukemias (AML3 subtype) with all-trans-retinoic acid has been shown to be an efficient alternative to chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_provenance.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion evidence source_evidence_literature NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_provenance.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion SIO_000772 1317749 NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_provenance.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion wasDerivedFrom befree-20150227 NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_provenance.
- NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_assertion wasGeneratedBy ECO_0000203 NP284593.RAHwnhvSbPacbbYMD1l1Z8CP_bggvtZ7yXKneMCVl5uKw130_provenance.